Adoptive NK‐cell transfer as a potential treatment paradigm for Wilms tumor: A preclinical study-Reference-Cited by-同舟云学术

Adoptive NK‐cell transfer as a potential treatment paradigm for Wilms tumor: A preclinical study

Published:2022-04-20 Issue:8 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Behfar Maryam¹,Muhammadnejad Samad²^ORCID,Abdolahi Shahrokh³⁴,Mohseni Rashin¹,Shoae‐Hassani Alireza⁵,Monzavi Seyed Mostafa²³,Hamidieh Amir Ali¹^ORCID

Affiliation:

1. Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute Tehran University of Medical Sciences Tehran Iran

2. Gene Therapy Research Center, Digestive Diseases Research Institute Tehran University of Medical Sciences Tehran Iran

3. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran

4. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran

5. Stem Cell and Regenerative Medicine Research Center Iran University of Medical Sciences Tehran Iran

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29676

Reference47 articles.

1. Current Recommendations, Controversies, and Potential Novel Approaches in the Treatment of Wilms Tumor

2. Biology and treatment of renal tumours in childhood

3. Antigen-independent killer cells prepared for adoptive immunotherapy: One source, divergent protocols, diverse nomenclature

4. The role of natural killer cell in gastrointestinal cancer: killer or helper

5. Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. Cancer immunotherapy of Wilms tumor: a narrative review;Future Oncology;2024-09-05